Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home›Services›Data, analytics & AI›Algorithm development

Data Analytics and AI Services

Algorithm Development for Training and Optimisation

Pubrica designs, trains, validates and optimises custom algorithms for healthcare, life sciences and pharmaceutical organisations. Our data scientists, biostatisticians and subject experts work with research groups, healthcare providers, pharmaceutical, biotech and medical device companies, and food and nutraceutical organisations that hold large, complex datasets under privacy and regulatory constraints. We develop AI, machine learning, deep learning and optimisation algorithms that automate workflows and support discovery, and we deliver the validated model with its code, environment, documentation, a benchmark against a baseline and a monitoring plan.

  • Domain-specific development: we work in healthcare, life sciences, pharma, medical devices, food and nutraceuticals, where data constraints and failure modes differ by field
  • Validation against held-out data: we apply correct cross-validation and report out-of-sample performance
  • Optimisation for your objective: we balance accuracy against latency, interpretability, cost and calibration, as most deployments require
  • Privacy and compliance from the start: HIPAA, GDPR and FDA or EMA expectations determine what can be built before any model is trained
  • Post-deployment support: we monitor models in production, because performance drifts as the population and recording practices change
Algorithm development deliverables Included services and exclusions

Design, training and optimisationIncluded

Validation against held-out dataIncluded

Documentation, code and benchmarksIncluded

Deployment and integrationIncluded

Regulatory clearance of the modelClient responsibility

Accuracy promised in advanceCannot be promised

Problem → designed → trained → validated → deployed

Included in every algorithm engagement
  • Baseline established before anything complex
  • Validated on data it has not seen
  • Objective and trade-offs agreed first
  • Code, environment and documentation delivered
  • Monitoring plan for after deployment
HIPAA, GDPR, FDA and EMACompliance requirements applied from the design stage
2–10 weeksBy package · multi-modal work quoted
Benchmarked against a baselinePerformance measured against a comparison
ISO 9001:2015Quality management certified · cert. H3CR9TCU20251212INDQM10N

Service Scope

Six Components of Every Algorithm Development Engagement

Each engagement is scoped in writing, with the objective, the trade-offs and the success criteria agreed before development begins.

Baseline performance assessment We first establish the performance of your current approach or of a simple model, so that any more complex model can be judged against it.

From the baseline reportDeep learning proposed for the classification taskA logistic regression on six features reaches 0.79 AUC. The neural network reaches 0.81, needs a GPU and cannot be explained to a regulator. The report recommends the regression and shows the comparison.

Algorithm design for your objective We design algorithms for the task the system must perform, which usually involves trade-offs between accuracy, latency, interpretability, cost and calibration.

From the design noteObjective: flag for review, not decide. That changes the metric from accuracy to recall at a fixed review capacity, and it changes the model. Agreed before development, not after the first evaluation.

Model training with a leakage-free pipeline We train models on real data, with preprocessing, feature selection and tuning fitted inside the training folds so that no information passes between training and test sets.

From the training logFeature selection on the full dataset, then nested CVSelection moved inside the outer folds. Reported performance dropped from 0.89 to 0.78, and 0.78 is the number that will hold.

Validation and stress testing We apply cross-validation, held-out testing and scenario analysis, including tests on data that differs slightly from the training set, as production data will.

From the validation reportPerformance by site: 0.81, 0.79, 0.80 and 0.62. The fourth site records the key variable differently. Reported rather than averaged away, because averaging it hides the one place the model fails.

Deployment and integration We integrate the algorithm into your systems, workflows or pipelines with the environment pinned and the code documented, so the production model is the validated one.

From the handoverContainer with pinned dependencies · inference code and preprocessing as one artefact · model card with intended use, training population and known limitations · rollback procedure.

Post-deployment monitoring We provide ongoing monitoring, fine-tuning and support, because a deployed model degrades as the population, recording practices and clinical pathway change.

From the monitoring plan“Retrain annually.”Input distribution monitored monthly against the training distribution, performance tracked where labels arrive, and a defined trigger for retraining rather than a calendar date.

Samples are illustrative and anonymised. Hover any one of them to play it again.

Types of Algorithms

Eight Types of Algorithms We Develop

We select the approach based on the data type, the operational constraints and whether the output must be explainable.

AI and machine learning algorithmsPredictive models for drug discovery, patient outcomes, nutrition science and life-sciences research, built and validated against held-out data.
Deep learning algorithmsNeural networks for medical imaging, computer vision, video and speech analysis — where the data volume justifies the complexity and the interpretability cost is acceptable.
Privacy and security algorithmsProtecting sensitive research and healthcare data while meeting HIPAA, GDPR and FDA or EMA requirements — including de-identification and privacy-preserving approaches.
Multi-objective optimisationAlgorithms that balance accuracy, efficiency, latency and cost, as most real deployments require.
Text and web miningExtracting information from clinical trial data, health records, regulatory documents and scientific literature, where the useful content is unstructured.
Data visualisation algorithmsAlgorithms that present complex outputs in a form decision-makers can read, including uncertainty as well as point estimates.
Workflow and business logic modelsAutomating processes in healthcare, pharma and food R&D, where a well-specified rule is often a better answer than a learned model.
Networking and IoT algorithmsCommunication and connectivity for connected medical devices and digital health systems, where reliability and latency constraints dominate.

Domains. Healthcare, life sciences, pharmaceuticals, medical devices, food and nutraceuticals. What we will not do: propose a complex model without comparing it to a simple baseline, report in-sample performance as performance, or build a clinical-decision algorithm without establishing first whether it is a regulated device.

Who we serve

Seven Client Groups We Support with Algorithm Development

Each client group has different requirements, whether the algorithm must satisfy a peer reviewer, a regulator, a production system or a clinician acting on its output.

Researchers and academicsAlgorithm development for biomedical research, clinical studies and computational modelling, reported to the standards that journal reviewers apply.
Healthcare and life sciences companiesAlgorithms for discovery, diagnostics, patient monitoring and personalised medicine, built inside the regulatory reality they will operate in.
Clinicians and healthcare providersPredictive and decision-support algorithms — where interpretability and calibration matter more than a marginal gain in discrimination.
Pharmaceutical and biotech firmsOptimisation for clinical trials, molecular simulation and large-scale development data, where the analysis often has to survive regulatory scrutiny.
Food and nutraceutical innovatorsNutrition modelling, product R&D, consumer insight and safety validation, with the evidence requirements those carry.
Industry and operations teamsOperational optimisation, forecasting and process automation, where a well-specified rule is frequently the better answer.
Regulators and policy makersTransparent, interpretable models for compliance, safety assessment and evidence-based decision-making, where a model nobody can explain is not usable.

Compliance and Standards

Algorithm Development Standards and Regulatory Frameworks

What governs an algorithm depends on what it is for. A research model and one that informs a clinical decision answer to very different requirements.

TRIPOD+AI, 2024

TRIPOD+AI (BMJ, 2024)

The reporting standard for clinical prediction models including machine learning ones, and the checklist a reviewer will apply.

GDPRand HIPAA

Data protection (GDPR, HIPAA and local regimes)

Where patient data is involved, what may be processed and where is settled before design rather than documented after it.

FDAand EMA

Software as a medical device (FDA and EMA expectations)

Where the algorithm informs a clinical decision it may be a regulated device. That changes the evidence, the documentation and the change-control requirements substantially.

ISO27001:2022

Information security management (ISO/IEC 27001:2022)

The current version of the information security standard. The 2013 edition has been superseded and its transition window has closed.

ICMJE Recommendations (January 2026)

Where the work is published, including declarations about data, code and AI tool use.

GCPICH E6(R3)

Good Clinical Practice (ICH E6(R3), January 2025)

For algorithms developed inside or alongside clinical trials.

ISO9001:2015

Quality management (cert. H3CR9TCU20251212INDQM10N)

How the work is run, recorded and reviewed — not a claim about algorithm performance.

Responsible Use of AI

Explainable and Defensible Algorithm Development

In algorithm development, AI is the product rather than a supporting tool. Reviewers, regulators and clinical partners need to know why a model was chosen and how it behaves when it is wrong, so every modelling decision is documented and explainable.

What we use it forWe use AI tools for hyperparameter search, code scaffolding that is read line by line before it runs, exploratory analysis that a person then reproduces, and finding and cleaning training data with provenance recorded.
What we do not use it forWe do not use AI to choose the target variable, the training population or the fairness criterion. We do not accept performance figures without a designed held-out test, and no model enters a clinical or regulatory setting without a named person accountable for it.
What goes in your declarationYour declaration states the tool, the stage at which it was used and the human oversight applied. Journals, funders and the ICMJE January 2026 update now expect this, and an undeclared tool found later is treated as a research integrity matter.

Why We Do Not Publish an AI Accuracy Figure

Accuracy figures for AI tools are usually reported by the companies that sell them.

Pubrica therefore does not quote its own accuracy figure, because it would carry the same conflict of interest. Instead, we tell you which tool was used on your project, at which stage, and what a human reviewer changed afterwards.

Methodology

Our Seven-Step Algorithm Development Methodology

The process runs from feasibility assessment at step one to post-deployment monitoring at step seven.

Step one

Requirement analysis and problem definition

We define what the algorithm is for, what data exists, which constraints apply and what success looks like, and we establish current performance as the baseline.

Step two

Data collection and preprocessing

We source, clean and normalise structured and unstructured data, and we identify and report bias and imbalance rather than correcting them silently.

Step three

Algorithm design and development

We design candidate approaches and compare them against a baseline, giving full consideration to the simplest adequate method.

Step four

Training and optimisation

We train models on real data and tune them for the objective agreed at step one, with all fitting done inside the training folds.

Step five

Validation and testing

We apply cross-validation, held-out testing and stress testing across sites, time periods and subgroups, and report performance by stratum as well as in aggregate.

Step six

Deployment and integration

We integrate the model into your systems and pipelines with the environment pinned, the code documented and a rollback path defined.

Step seven

Monitoring and support

We monitor input drift and performance where labels arrive, with a defined retraining trigger, because production data differs from training data.

Request a Free Algorithm Feasibility Assessment

We provide a written note on whether the problem is tractable with your data, a sensible baseline, the approach we would try first and the realistic performance ceiling. It is delivered within two business days at no charge, including when a simple rule would be sufficient.

What you provide
The problemWhat decision or task it automates
The dataA representative sample, with its labels
The constraintLatency, interpretability, hardware
The baselineWhat happens today, and how well
The governanceConsent, regulation, deployment setting
The destinationResearch, product, or regulated use

Please tell us what happens today and how well it works. If an algorithm cannot outperform the existing rule, that is a useful finding, and it is far less costly to establish at the start.

Our experts

Your Algorithm Development Team

A named team of data scientists, statisticians and subject specialists stays with your project from scoping to delivery. The handover records who completed each stage, and your project coordinator introduces each member by name before work begins.

Subject matter expertClinical or scientific expert matched to your topic

Reviews the scientific content for accuracy and confirms that each conclusion is supported by the evidence. Matched to your field rather than allocated from a rota.

OwnsScientific accuracy and interpretation
Reads againstThe study protocol and current literature
FieldMatched to your topic
BiostatisticianStatistical input where the work reports analysed data

Checks that statistical methods, tables and conclusions are consistent with the analysis plan and that the analysis can be reproduced.

OwnsStatistical accuracy
Reads againstICH E9 and the statistical analysis plan
ToolsR, SAS, Stata, Python
Data specialistData handling, cleaning and documentation

Prepares, cleans and documents the data so that every step from raw data to final output can be traced and reproduced.

OwnsData handling and documentation
Reads againstThe data management plan and applicable data standards
OutputDocumented, reproducible datasets
Second reviewerIndependent check of code and outputs

Independently checks code, tables and outputs against the analysis plan. Discrepancies are logged and resolved before delivery.

OwnsIndependent quality control
Reads againstThe analysis plan and outputs
Signed off byProject lead

Sample work

Sample Work: Classification Model as Proposed and as Delivered

Step through the findings one at a time. The delivered model is simpler than the proposed one, performs within 0.02 AUC of it, and is suitable for clinical deployment.

6 changes, each explained

As proposed. Deep learning classifier on 40,000 records across four sites.

  • Neural network, 3 layers
  • Feature selection on the full dataset
  • Reported AUC 0.89
  • Performance reported in aggregate
  • No baseline established
  • “Retrain annually”

As delivered. Simpler, validated by site, and deployable.

  • Penalised logistic regression, 6 features — within 0.02 AUC of the network
  • Selection moved inside the outer folds — 0.89 became 0.78
  • AUC 0.78 out of sample, calibration slope 0.91
  • By site: 0.81, 0.79, 0.80, 0.62 — site 4 codes the key variable differently
  • Baseline: the existing rule scores 0.71. The model earns its place, narrowly
  • Drift monitored monthly, retraining triggered by a defined threshold

Figures illustrative; the clinical task, record count and values are changed. Every one of these findings is one we see regularly.

Illustrative · task and values changedStandard package · validated by site

Benefits

Benefits of Pubrica Algorithm Development

Each of these is checkable in your own code, report and monitoring. None is a promise of a performance figure, which is what the validation exists to establish.

01 Measurable improvement against a baselineWithout knowing what the current approach achieves, any model performance is a number without a comparison — and it frequently turns out that a simple rule was already close.
02 Consideration of the simplest adequate modelIn clinical and regulated settings, interpretable and defensible usually beats marginally better. The comparison is made and reported rather than skipped.
03 Validation that reflects deploymentWe test across sites, time periods and subgroups, because a model that performs well on average can still fail consistently at one location.
04 Compliance built into the designHIPAA, GDPR and, where it applies, medical device regulation decide what can be built. Discovering that after development means rebuilding.
05 Production model identical to the validated modelPinned environment, documented code and the preprocessing bundled with the model, so the production artefact is the tested one.
06 Ongoing performance monitoringWe track input drift, measure performance where labels arrive and define a retraining trigger, because model degradation is otherwise difficult to detect.

Packages

Algorithm Development Service Packages

Each package is priced on the state of the data, whether the problem is single- or multi-modal, and whether deployment and monitoring are in scope. The feasibility assessment is free and comes first.

Basic

Foundational algorithm development

Startups, small research projects and proof-of-concept studies

Quoted per projectPriced on dataset size

Delivery 2–3 weeks

  • ✓Requirement analysis and feasibility study
  • ✓Baseline established before modelling
  • ✓Algorithm design for structured data
  • ✓Training and validation against held-out data
  • ✓Performance report with recommendations

Suitable for establishing whether the problem justifies a larger engagement.

View a sample Request a quote
Standard

Optimised algorithm development

Research groups and organisations that need a validated model integrated with their data pipelines

Quoted per projectPriced on data complexity

Delivery 4–6 weeks

  • ✓Comprehensive requirement gathering
  • ✓Design for structured and unstructured data
  • ✓Training, optimisation and nested cross-validation
  • ✓Validation stratified by site, period and subgroup
  • ✓Integration with your existing data pipelines
  • ✓Benchmarking against the baseline, and documentation

Our most commonly selected package. Stratified validation often produces the most useful findings.

View a sample Request a quote
Premium

Advanced and custom algorithm solutions

Large-scale research, enterprise applications and regulated settings

Quoted per projectPriced on scope and deployment

Delivery 6–10 weeks

  • ✓Full consultation and strategic planning
  • ✓Custom development for multi-modal data
  • ✓Advanced training with AI and machine learning methods
  • ✓Real-time testing and fine-tuning
  • ✓Deployment-ready artefact with pinned environment and model card
  • ✓Post-deployment monitoring and support

Where the algorithm informs a clinical decision, regulatory classification is established at scoping, because it determines the evidence and documentation required.

View a sample Request a quote

Send the problem and a data sample and we will assess feasibility free, including what a sensible baseline looks like. Ongoing monitoring is quoted against a schedule.

Quality Assurance

Our Service Commitments

Our service commitment, its limits and the remedy we offer are set out below.

The Pubrica guarantee

Performance Benchmarked Against a Defined Baseline

Every engagement establishes what the current approach achieves before anything is built, and reports the new model against it on data neither has seen.

01

Baseline established first

We measure current performance or the performance of a simple model, so that new results can be compared against it.

02

Stratified out-of-sample reporting

Results are reported by site, period and subgroup as well as in aggregate, because aggregate figures can hide a failure.

03

Simplest adequate model considered

Where an interpretable model performs within a meaningful margin, the comparison is in the report and the recommendation explains the choice.

04

Advice when a simple rule is sufficient

Some problems do not need a model, and we will tell you when that is the case.

Client Stories

“They guided us through the whole process, from model selection to validation. The recommendation was a simpler model than we had planned, and it was the right one.”
Faisal Al-QahtaniAI research scientist

Saudi Arabia

FAQs

Algorithm Development FAQs

If yours is not here, ask an expert — no quote required.

Healthcare and life sciences researchers, data science teams, technology companies and organisations that need predictive analytics, automation or decision support inside a regulated or evidence-driven environment.

In each case, the output must be defensible to a reviewer, a regulator or a clinician, not only functional.

Supervised, unsupervised and reinforcement learning; predictive and prescriptive models; rules-based and heuristic algorithms; computer vision, natural language processing and speech recognition; and multi-objective optimisation.

The choice depends on the data, the constraints and whether the output must be explainable; the need for explainability often narrows the options most.

Against a baseline, on data it has not seen. We establish what the current approach achieves, then report the new model out of sample with preprocessing, feature selection and tuning all fitted inside the training folds.

Performance is reported by site, period and subgroup rather than only in aggregate, because an average conceals the place where it fails — and that is usually the finding that matters most.

Typically: requirement analysis and design, one to two weeks; development and initial testing, three to six weeks; optimisation and validation, two to four weeks; deployment and documentation, one to two weeks.

The variable that moves this most is data condition. A dataset that needs harmonising before anything can be trained adds more time than the modelling itself takes.

Yes, and we recommend it for any model that informs real decisions. Input distributions are monitored against the training distribution, performance is tracked where labels arrive, and retraining is triggered by a defined threshold.

A model degrades as the population and recording practices change, and its outputs can continue to look reasonable while this happens.

Software executes rules you specify. An algorithm of this kind learns from data, which means its behaviour depends on data you did not write and may not fully understand.

The practical consequence is that the work is mostly validation. In conventional software you test whether it does what you specified; here you are establishing what it does at all, and on which populations.

Yes, and the first question is whether what you are building is a regulated device. An algorithm that informs a clinical decision may be software as a medical device, which changes the evidence, the documentation and the change-control requirements substantially.

We establish that classification at scoping, because discovering it after development requires substantial rework.

Request a Free Algorithm Feasibility Assessment

Within two business days and at no charge, we will assess whether the problem is tractable with your data, a sensible baseline, the approach we would try first and the realistic performance ceiling, including when a simple rule would be sufficient.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.